EDIL3 and hepatocellular carcinoma: EDIL3 has been identified as a novel regulator of EMT in hepatocellular carcinoma cells, as the increased expression of EDIL3 by miRNA-137 downregulation triggers ERK and TGF-β activation via interaction with the integrin αVβ3 (20).